Browsing Over 146 Presentations

Sort By
New indications in CNS tumours (ID 2) Educational session

Q&A (ID 12)

Lecture Time
15:50 - 16:00
Session Name
New indications in CNS tumours (ID 2)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Future of adjuvant and neoadjuvant treatment (ID 1) Educational session

Q&A (ID 7)

Lecture Time
15:50 - 16:00
Session Name
Future of adjuvant and neoadjuvant treatment (ID 1)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
New indications in CNS tumours (ID 2) Educational session

Antibody-fusion constructs for the treatment of glioblastoma (ID 8)

Lecture Time
14:30 - 14:50
Speakers
  • Patrick Roth (Zurich, CH)
Session Name
New indications in CNS tumours (ID 2)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Patrick Roth (Zurich, CH)
Future of adjuvant and neoadjuvant treatment (ID 1) Educational session

What are the right surrogate endpoints for peri-operative immune therapy (ID 3)

Lecture Time
14:30 - 14:50
Speakers
  • Thomas B. Powles (London, GB)
Session Name
Future of adjuvant and neoadjuvant treatment (ID 1)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Thomas B. Powles (London, GB)
New indications in CNS tumours (ID 2) Educational session

Vaccine strategies for gliomas (ID 9)

Lecture Time
14:50 - 15:10
Speakers
  • Michael Platten (Mannheim, DE)
Session Name
New indications in CNS tumours (ID 2)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Michael Platten (Mannheim, DE)
Future of adjuvant and neoadjuvant treatment (ID 1) Educational session

What are the long terms risk of peri-operative immune therapy and how much benefit is required to offset this? (ID 4)

Lecture Time
14:50 - 15:10
Speakers
  • Brian I. Rini (Nashville, US)
Session Name
Future of adjuvant and neoadjuvant treatment (ID 1)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Brian I. Rini (Nashville, US)
New indications in CNS tumours (ID 2) Educational session

CAR T-cells for brain tumours (ID 10)

Lecture Time
15:10 - 15:30
Speakers
  • Denis Migliorini (Geneva, CH)
Session Name
New indications in CNS tumours (ID 2)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Denis Migliorini (Geneva, CH)
Future of adjuvant and neoadjuvant treatment (ID 1) Educational session

Biomarkers for immune checkpoint inhibitors in the perioperative setting in breast cancer (ID 5)

Lecture Time
15:10 - 15:30
Speakers
  • Michail Ignatiadis (Brussels, BE)
Session Name
Future of adjuvant and neoadjuvant treatment (ID 1)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Michail Ignatiadis (Brussels, BE)
New indications in CNS tumours (ID 2) Educational session

Immunotherapy of leptomeningeal metastases (ID 11)

Lecture Time
15:30 - 15:50
Speakers
  • Ghazaleh Tabatabai (Tuebingen, DE)
Session Name
New indications in CNS tumours (ID 2)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • Ghazaleh Tabatabai (Tuebingen, DE)
Future of adjuvant and neoadjuvant treatment (ID 1) Educational session

Exploring beyond PD-(L)1 therapy in peri-operative disease (ID 6)

Lecture Time
15:30 - 15:50
Speakers
  • David F. McDermott (Boston, US)
Session Name
Future of adjuvant and neoadjuvant treatment (ID 1)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
  • David F. McDermott (Boston, US)
Optimising I-O drug clinical development (ID 3) Educational session

Q&A (ID 20)

Lecture Time
17:50 - 18:00
Session Name
Optimising I-O drug clinical development (ID 3)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Direct intratumoural injection of immunotherapy (ID 4) Educational session

Synthetic TLR-3 ligands (ID 21)

Lecture Time
16:30 - 16:50
Speakers
  • Bettina Werle (Lyon, FR)
Session Name
Direct intratumoural injection of immunotherapy (ID 4)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
16:30 - 18:00
Authors
  • Bettina Werle (Lyon, FR)